Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU

Francisco Mesonero, Yamile Zabana, Agnès Fernández-Clotet, Eduardo Leo-Carnerero, Berta Caballol, Andrea Núñez-Ortiz, María José García, Federico Bertoletti, Alejandro Mínguez, Gerard Suris, Begoña Casis, Rocío Ferreiro-Iglesias, Margalida Calafat, Itxaso Jiménez, José Miranda-Bautista, Luis Javier Lamuela, Ingrid Fajardo, Leyanira Torrealba, Rodrigo Nájera, Rosa María Sáiz-Chumillas, Irene González, Miren Vicuña, Natalia García-Morales, Ana Gutiérrez, Alicia López-García, José Manuel Benítez, Cristina Rubín de Célix, Coral Tejido, Eduard Brunet, Alejandro Hernández-Camba, Cristina Suárez, Iago Rodríguez-Lago, Marta Piqueras, Andrés Castaño, Laura Ramos , Ana Sobrino, María Carmen Rodríguez-Grau, Alfonso Elosua, Miguel Montoro, Ruth Baltar, José María Huguet, Benito Hermida, Antonio Caballero-Mateos, Luis Sánchez-Guillén, Abdel Bouhmidi, Ramón Pajares, Iria Baston-Rey, Antonio López-Sanromán, Agustin Albillos and Manuel Barreiro-de Acosta On behalf of the GETECCU Young Members Group

Current management of bowel failure due to crohn’s disease in spain: results of the GETECCU survey

Cristina Suárez Ferrer, María Dolores Martín-Arranz, Eduardo Martín-Arranz, Francisco Rodríguez Moranta, Alicia López García, José Manuel Benítez Cantero, Francisco Mesonero Gismero, Manuel Barreiro Acosta

Adherence to endoscopic surveillance for advanced lesions and colorectal cancer in inflammatory bowel disease: an AEG and GETECCU collaborative cohort study

Maria Pilar Ballester,Francisco Mesonero,Pablo Flórez-Diez,Concepción Gómez,Esteban Fuentes-Valenzuela,Noelia Martín,Carla Senosiain,Milagros Vela,Agnes Fernández-Clotet,Pablo Pérez,Cristina Rubín de Célix,Cristina Calviño-Suárez,Benito Hermida,Roser Muñoz,Maria González-Vivo,Eduard Brunet,Nuria Jiménez,Belén Botella,Jorge Yebra,Cristina Suárez-Ferrer,Abdel Bouhmidi,Antonio López-Serrano,Ángel Ponferrada,Carmen Dueñas,Miguel Mínguez,Young Group of AEG and GETECCU

SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project.

Ferreiro-Iglesias R, Hernández-Camba A, Serrano Labajos R, Rodríguez-Lago I, Zabana Y, Barreiro-de Acosta M; Young Group of Geteccu, ACCU Spain. Gastroenterol Hepatol. 2021 Aug 25:S0210-5705(21)00246-6. doi: 10.1016/j.gastrohep.2021.08.004. Epub ahead of print. PMID: 34453969; PMCID: PMC8386133.

Use of capsule endoscopy in inflammatory bowel disease in clinical practice in Spain. Results from a national survey.

Elosua González A, Nantes Castillejo Ó, Fernández-Urién Sainz I, López-García A, Murcia Pomares Ó, Zabana Y; en nombre de Grupo Joven GETECCU y del Grupo Joven de AEG. Gastroenterol Hepatol. 2021 Dec;44(10):696-703. English, Spanish. doi: 10.1016/j.gastrohep.2021.02.013. Epub 2021 Apr 16. PMID: 33872625.

 

Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu

María José García, Montserrat Rivero, José Miranda-Bautista, Iria Bastón-Rey, Francisco Mesonero, Eduardo Leo-Carnerero, Diego Casas-Deza, Carmen Cagigas Fernández, Albert Martin-Cardona, Ismael El Hajra, Nerea Hernández-Aretxabaleta, Isabel Pérez-Martínez, Esteban Fuentes-Valenzuela, Nuria Jiménez, Cristina Rubín de Célix, Ana Gutiérrez, Cristina Suárez Ferrer, José María Huguet, Agnes Fernández-Clotet, María González-Vivó, Blanca Del Val, Jesús Castro-Poceiro, Luigi Melcarne, Carmen Dueñas, Marta Izquierdo, David Monfort, Abdel Bouhmidi, Patricia Ramírez De la Piscina, Eva Romero, Gema Molina, Jaime Zorrilla, Cristina Calvino-Suárez, Eugenia Sánchez, Andrea Nuñez, Olivia Sierra, Beatriz Castro, Yamile Zabana, Irene González-Partida, Saioa De la Maza, Andrés Castaño, Rodrigo Nájera-Muñoz, Luis Sánchez-Guillén, Micaela Riat Castro, José Luis Rueda, José Manuel Benítez, Pedro Delgado-Guillena, Carlos Tardillo, Elena Peña, Santiago Frago-Larramona, María Carmen Rodríguez-Grau, Rocío Plaza ,Pablo Pérez-Galindo, Jesús Martínez-Cadilla, Luis Menchén, Manuel Barreiro-De Acosta, Rubén Sánchez-Aldehuelo, María Dolores De la Cruz, Luis Javier Lamuela, Ignacio Marín, Laura Nieto-García, Antonio López-San Román, José Manuel Herrera, María Chaparro, Javier P. Gisbert, and on behalf of the Young Group of GETECCU.

Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease

Iago Rodríguez-Lago, Javier Del Hoyo, Alexandre Pérez-Girbés, Alejandro Garrido-Marín, María José Casanova, María Chaparro, Agnès Fernández-Clotet, Jesús Castro-Poceiro, María José García, Sara Sánchez, Rocío Ferreiro-Iglesias, Iria Bastón, Marta Piqueras, Lola Esteba i Bech de Careda, Raquel Mena, Cristina Suárez, Joaquín Poza Cordón, Alicia López-García, Lucía Márquez, Maite Arroyo,Erika Alfambra, Mónica Sierra, Noelia Cano, Pedro Delgado-Guillena, Víctor Morales-Alvarado, Juan Carlos Aparicio,
Iván Guerra, Carolina Aulló, Olga Merino, Laura Arranz, María Araceli Hidalgo, Jordina Llaó, Rocío Plaza, Gema Molina, Paola Torres, Pablo Pérez-Galindo, María Giselle Romero, Claudia Herrera-de Guise, Edisa Armesto,
Francisco Mesonero, Santiago Frago-Larramona, José Manuel Benítez, Marta Calvo, María del Carmen López Martín, Ainara Elorza, Alejandro Larena, Elena Peña, María del Carmen Rodríguez-Grau, Jaime de Miguel-Criado, Belén Botella, José Antonio Olmos, Laura López, Urko Aguirre, Javier P. Gisbert, on behalf of the Young GETECCU

Tacrolimus induces short-term but not long-term clinical response in inflammatory bowel disease

Iago Rodríguez-Lago, Jesús Castro-Poceiro, Agnès Fernández-Clotet, Francisco Mesonero, Antonio López-Sanromán, Alicia López-García, Lucía Márquez, Ariadna Clos-Parals, Fiorella Cañete, Miren Vicuña, Óscar Nantes, Olga Merino, Virginia Matallana, Jordi Gordillo, Ainara Elorza, Raquel Vicente, María José Casanova, Rocío Ferreiro-Iglesias, Pablo Pérez-Galindo, José Manuel Benítez, Carlos Taxonera, María José García, Eduardo Martín, Margalida Calafat, Albert Martin-Cardona, Fernando Muñoz, Josep Oriol Miquel-Cusachs, Empar Sáinz, Urko Aguirre, Javier P. Gisbert; on behalf of the Young GETECCU Group.
Aliment Pharmacol Ther. 2020;51:870–879.

Efficacy of adalimumab rescue therapy in patients with chronic refractory pouchitis previously treated with infliximab: a case series.

Barreiro-de Acosta M, García-Bosch O, Gordillo J, Mañosa M, Menchén L, Souto R, Marin-Jimenez I.Grupo Joven GETECCU. Eur J Gastroenterol Hepatol. 2012 Jul;24(7):756-8

Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: a multicenter study.

Barreiro-de Acosta M, García-Bosch O, Souto R, Mañosa M, Miranda J, García-Sanchez V, Gordillo J, Chacon S, Loras C, Carpio D, Maroto N, Menchén L, Rojas-Feria M, Sierra M, Villoria A, Marin-Jimenez I; Grupo joven GETECCU.Inflamm Bowel Dis. 2012 May;18(5):812-7

High smoking cessation rate in Crohn’s disease patients after physician advice- the TABACROHN Study

Nunes T, Etchevers MJ, Merino O, Gallego S, García-Sánchez V, Marín-Jiménez I, Menchén L, Barreiro-de Acosta M, Bastida G, García S, Gento E, Ginard D, Martí E, Gomollón F, Arroyo M, Monfort D, García-Planella E, Gonzalez B, Loras C, Agustí C, Figueroa C, Sans M; TABACROHN Study Group of GETECCU. J Crohns Colitis. 2013 Apr;7(3):202-7

Does smoking influence Crohn’s disease in the biologic era? The TABACROHN study

Nunes T, Etchevers MJ, Merino O, Gallego S, García-Sánchez V, Marín-Jiménez I, Menchén L, Barreiro-de Acosta M, Bastida G, García S, Gento E, Ginard D, Gomollón F, Arroyo M, Monfort D, García-Planella E, Gonzalez B, Loras C, Agustí C, Figueroa C, Sans M; TABACROHN Study Group of GETECCU, Spanish Working Group in Crohn’s Disease and Ulcerative Colitis. Inflamm Bowel Dis. 2013 Jan;19(1):23-9

Manejo de la colitis ulcerosa aguda grave en España: Resultados de una encuesta sobre práctica clínica

Rodríguez-Lago I, Ferreiro-Iglesias R, Nos P, Gisbert JP; en representación del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU).
Gastroenterol Hepatol. 2019 Feb;42(2):90-101. doi: 10.1016/j.gastrohep.2018.09.002. Epub 2018 Oct 4.